1. Home
  2. EKSO vs TRIB Comparison

EKSO vs TRIB Comparison

Compare EKSO & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$9.90

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.82

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EKSO
TRIB
Founded
2005
1992
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
18.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EKSO
TRIB
Price
$9.90
$0.82
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.50
N/A
AVG Volume (30 Days)
203.4K
257.9K
Earning Date
03-02-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,749,000.00
$48,570,000.00
Revenue This Year
N/A
$13.51
Revenue Next Year
$54.65
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.73
$0.48
52 Week High
$12.70
$3.44

Technical Indicators

Market Signals
Indicator
EKSO
TRIB
Relative Strength Index (RSI) 61.62 50.07
Support Level $8.39 $0.78
Resistance Level $10.76 $0.96
Average True Range (ATR) 0.94 0.08
MACD 0.04 0.01
Stochastic Oscillator 75.35 47.22

Price Performance

Historical Comparison
EKSO
TRIB

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: